The metabolomics of asthma control: A promising link between genetics and disease

Immunity, Inflammation and Disease

Volumn 3, Issue 3, 2015, Pages 224-238

  McGeachie, Michael J ^a   Dahlin, Amber ^a   Qiu, Weiliang ^a   Croteau Chonka, Damien C ^a   Savage, Jessica ^a   Wu, Ann Chen ^a   Wan, Emily S ^a   Sordillo, Joanne E ^a   Al Garawi, Amal ^a   Martinez, Fernando D ^b   Strunk, Robert C ^c   Lemanske, Robert F ^d   Liu, Andrew H ^e   Raby, Benjamin A ^a   Weiss, Scott ^a   Clish, Clary B ^f   Lasky Su, Jessica A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e Children's Hospital Colorado   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Albuterol; Asthma; Epigenetics; Genetics; Metabolomics

Indexed keywords

EID: 85011570000     PISSN: None     EISSN: 20504527     Source Type: Journal    
DOI: 10.1002/iid3.61     Document Type: Article

References (56)

1. Association, A. L. 2010. Trends in asthma morbidity and mortality. American Lung Association, Washington, DC.
2. Patel, M., J. Pilcher, H. K. Reddel, et al. 2013. Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin. Exp. Allergy 43:1144–1151.
3. Barnett, S. B., and T. A. Nurmagambetov. 2011. Costs of asthma in the United States: 2002–2007. J. Allergy Clin. Immunol. 127:145–152.
4. Bateman, E. D., S. S. Hurd, P. J. Barnes, et al. 2008. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 31:143–178.
5. Doi, A., I. H. Park, B. Wen, et al. 2009. Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41:1350–1353.
6. Irizarry, R. A., C. Ladd-Acosta, B. Wen, et al. 2009. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41:178–186.
7. Moffatt, M. F., I. G. Gut, F. Demenais, et al. 2010. A large-scale, consortium-based genomewide association study of asthma. N. Engl. J. Med. 363:1211–1221.
8. Rhee, E. P., and R. E. Gerszten. 2012. Metabolomics and cardiovascular biomarker discovery. Clin. Chem. 58:139–147.
9. Wang, T. J., M. G. Larson, R. S. Vasan, et al. 2011. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17:448–453.
10. Rhee, E. P., and R. Thadhani. 2011. New insights into uremia-induced alterations in metabolic pathways. Curr. Opin. Nephrol. Hypertens. 20:593–598.
11. Nicholson, J. K., and I. D. Wilson. 2003. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2:668–676.
12. Raamsdonk, L. M., B. Teusink, D. Broadhurst, et al. 2001. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat. Biotechnol. 19:45–50.
13. Forno, E, and JC. Celedon. 2012. Predicting asthma exacerbations in children. Curr. Opin. Pulmon. Med. 18:63–69.
14. Jung, J., S. H. Kim, H. S. Lee, et al. 2013. Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. Clin. Exp. Allergy 43:425–433.
15. Mattarucchi, E., E. Baraldi, and C. Guillou. 2012. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed. Chromatogr. 26:89–94.
16. Gahleitner, F., C. Guallar-Hoyas, C. S. Beardsmore, H. C. Pandya, and C. P. Thomas. 2013. Metabolomics pilot study to identify volatile organic compound markers of childhood asthma in exhaled breath. Bioanalysis 5:2239–2247.
17. Carraro, S., S. Rezzi, F. Reniero, et al. 2007. Metabolomics applied to exhaled breath condensate in childhood asthma. Am. J. Respir. Crit. Care Med. 175:986–990.
18. Saude, E. J., C. D. Skappak, S. Regush, et al. 2011. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J. Allergy Clin. Immunol. 127:757–764; e1–6.
19. Carraro, S., G. Giordano, F. Reniero, et al. 2013. Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy 68:110–117.
20. Fitzpatrick, A. M., J. T. Holbrook, C. Y. Wei, M. S. Brown, R. A. Wise, and W. G. Teague. 2014. Exhaled breath condensate pH does not discriminate asymptomatic gastro-esophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma. J. Allergy Clin. Immunol. Pract. 2:579–586; e7.
21. Loureiro, C. C., I. F. Duarte, J. Gomes, et al. 2014. Urinary metabolomic changes as a predictive biomarker of asthma exacerbation. J. Allergy Clin. Immunol. 133:261–263; e1–5.
22. Guilbert, T. W., W. J. Morgan, M. Krawiec, et al. 2004. The prevention of early asthma in kids study: design, rationale and methods for the Childhood Asthma Research and Education network. Control. Clin. Trials 25:286–310.
23. Denlinger, L.C., C.A. Sorkness, V.M. Chinchilli, and R.F. Lemanske Jr. 2007.Guideline-definingasthmaclinicaltrialsofthe National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J. Allergy Clin. Immunol. 119:3–11; quiz 2–3.
24. Smyth, G. K. 2005. Limma: linear models for microarray data. Pp. 397–420 in R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, and W. Huber, eds. Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York.
25. Benjamini, Y, and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc. 57:289–300.
26. Purcell, S., B. Neale, K. Todd-Brown, et al. 2007. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81:559–575.
27. McGeachie, M. J., H. H. Chang, and S. T. Weiss. 2014. CGBayesNets: conditional Gaussian Bayesian Network learning and inference with mixed discrete and continuous data. PLoS Comput. Biol. 10:e1003676.
28. Heckerman, D., and D. Gieger. 1995. Learning Bayesian networks: a unification for discrete and Gaussian domains. Uncertainty in Artificial Intelligence: Morgan Kaufmann.
29. Rogers, A. J., M. McGeachie, R. M. Baron, et al. 2014. Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS ONE 9:e87538.
30. Jiang, X., R. E. Neapolitan, M. M. Barmada, and S. Visweswaran. 2011. Learning genetic epistasis using Bayesian network scoring criteria. BMC Bioinformatics 12:89.
31. Silander, T., P. Kontkanen, and P. Myllymaki. 2002. On sensitivity of the MAP Bayesian network structure to the equivalent sample size parameter. Pp. 360–367 in R. P. Loui, and L van der Gaag, eds. Uncertainty in artificial intelligence. AUAI Press, Corvallis, Oregon.
32. Xia, J., and D. S. Wishart. 2010. MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26:2342–2344.
33. Kamburov, A., R. Cavill, T. M. Ebbels, R. Herwig, and H. C. Keun. 2011. Integrated pathway-level analysis of transcrip-tomics and metabolomics data with IMPaLA. Bioinformatics 27:2917–2918.
34. Zhang, B., S. Kirov, and J. Snoddy. 2005. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic acids Res. 33:W741–W748.
35. Thorn, C. F., T. E. Klein, and R. B. Altman. 2013. PharmGKB: the pharmacogenomics knowledge base. Methods Mol. Biol. 1015:311–320.
36. Warde-Farley, D., S. L. Donaldson, O. Comes, et al. 2010. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 38:W214–W220.
37. Lamb, J., E. D. Crawford, D. Peck, et al. 2006. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929–1935.
38. Halleck, M. S., J. J. Lawler, S. Blackshaw, et al. 1999. Differential expression of putative transbilayer amphipath transporters. Physiol. Genomics 1:139–150.
39. Meguro, M., A. Kashiwagi, K. Mitsuya, et al. 2001. A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome. Nat. Genet. 28:19–20.
40. Van Veldhoven, P. P. 2010. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J. Lipid Res. 51:2863–2895.
41. Tantisira, K. G., J. Lasky-Su, M. Harada, et al. 2011. Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N. Engl. J. Med. 365:1173–1183.
42. Sleiman, P. M., K. Annaiah, M. Imielinski, et al. 2008. ORMDL3 variants associated with asthma susceptibility in North Americans of European ancestry. J. Allergy Clin. Immunol. 122:1225–1227.
43. Ferreira, M. A., A. F. McRae, and S. E. Medland, et al. 2011. Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia. Eur. J. Hum. Genet. 19:458–464.
44. Galanter, J., S. Choudhry, C. Eng, et al. 2008. ORMDL3 gene is associated with asthma in three ethnically diverse populations. Am. J. Respir. Crit. Care Med. 177:1194–1200.
45. Kerin, N. Z., and M. Rubenfire. 1989. Detection of amiodarone pulmonary toxicity. J. Am. Coll. Cardiol. 13:261–262.
46. Robinson, N. E., F. J. Derksen, M. A. Olszewski, and V. A. Buechner-Maxwell. 1996. The pathogenesis of chronic obstructive pulmonary disease of horses. Br. Vet. J. 152:283– 306.
47. Henricks, P. A., F. Engels, H. J. van der Linde, J. Garssen, and F. P. Nijkamp. 1995. 13-Hydroxy-linoleic acid induces airway hyperresponsiveness to histamine and methacholine in guinea pigs in vivo. J. Allergy Clin. Immunol. 96:36–43.
48. Pike, K. C., P. C. Calder, H. M. Inskip, et al. 2012. Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years. Clin. Dev. Immunol. 2012:474613.
49. Huang X.P.,Y. Pi, A.J. Lokuta, M.L. Greaser and J.W. Walker. 1997. Arachidonic acid stimulates protein kinase C-epsilon redistribution in heart cells. J. Cell Sci. 110(Pt 14):1625–1634.
50. Marinero, M. J., S. Ropero, B. Colas, J. C. Prieto, and M. P. Lopez-Ruiz. 2000. Modulation of guanosine triphosphatase activity of G proteins by arachidonic acid in rat Leydig cell membranes. Endocrinology 141:1093–1099.
51. Graler, M. H., R. Grosse, A. Kusch, E. Kremmer, T. Gudermann, and M. Lipp. 2003. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J. Cell Biochem. 89:507–519.
52. Offermanns, S., Y. H. Hu, and M. I. Simon. 1996. Galpha12 and galpha13 are phosphorylated during platelet activation. J. Biol. Chem. 271:26044–26048.
53. Wenzel, S. E. 1997. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 17:3S–12S.
54. Lai, W. Q., W. S. Wong, and B. P. Leung. 2011. Sphingosine kinase and sphingosine 1-phosphate in asthma. Biosci. Rep. 31:145–150.
55. Worgall, T. S., A. Veerappan, B. Sung, et al. 2013. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. Sci. Transl. Med. 5:186ra67.
56. Bjornsdottir U. S., Holgate S. T., Reddy P. S., et al. Pathways activated during human asthma exacerbation as revealed by gene expression patterns in blood. PLoS ONE 2011;6:e21902.